Fingerprint
Dive into the research topics of 'Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically